Grifulvin V is indicated for onychomycosis caused by dermatophytes, affecting both fingernails and toenails. Treatment duration for nail infections is typically longer (up to 12 weeks) because nails grow slowly and the drug must accumulate in the nail plate.
Griseofulvin can reduce the effectiveness of oral contraceptives. Women using hormonal birth control should employ an additional non-hormonal method (e.g., condoms) while on Grifulvin V and for at least one month after completing therapy.
A mild rash is a common side effect, but any widespread or severe skin reaction (especially with blistering or fever) warrants immediate medical evaluation, as it could signal a serious hypersensitivity reaction.
Yes. Griseofulvin is better absorbed when taken with a fatty meal. Consuming the pill with food improves its bioavailability and therapeutic effect.
Visible improvement often begins within 2-3 weeks, but full resolution may require 4-6 weeks of consistent therapy. Continuing the full prescribed course is essential even if symptoms improve early.
Moderate alcohol consumption does not directly interact with griseofulvin, but excessive alcohol can increase liver strain. Patients with pre-existing liver disease should limit alcohol intake.
Grifulvin V is marketed as a 250 mg pill. A liquid formulation is not commercially available for this brand; pediatric dosing, when needed, is typically achieved by prescribing compounded preparations under specialist supervision.
Griseofulvin is not a controlled substance and is not screened for in standard employment or athletic drug tests. However, specific testing panels may vary, so checking with the testing authority is advisable.
Both are oral antifungals, but terbinafine often achieves faster symptom relief and has a shorter treatment duration for tinea pedis. Griseofulvin may be preferred when terbinafine is contraindicated or when the infecting organism is known to be susceptible to griseofulvin.
Do not keep unused medication for future use. Return any remaining tablets to a pharmacy or follow local hazardous waste disposal guidelines to ensure safe disposal.
Grifulvin V is a prescription antifungal medication that contains the active ingredient griseofulvin. It is supplied as a 250 mg pill and is used to treat fungal infections of the skin, hair, and nails caused by dermatophytes. In Hong Kong, griseofulvin-containing products are regulated under the Pharmacy and Poisons Ordinance and require a medical prescription. The medication is classified as an oral systemic antifungal.
Griseofulvin interferes with the ability of dermatophyte fungi to grow and divide. After oral absorption, the drug is distributed to keratin-rich tissues such as the epidermis, hair shafts, and nails. It binds to fungal microtubules, disrupting mitosis and preventing the fungus from replicating. Because griseofulvin accumulates in keratin, it remains at the site of infection for several weeks, allowing the infected tissue to be replaced by new, fungus-free growth. Onset of action typically occurs within a few days, but full clinical improvement may require several weeks of therapy.
Grifulvin V is approved in Hong Kong for the treatment of dermatophytosis, including:
These infections are caused by fungi that invade the outer layers of skin, hair, or nails. Griseofulvin’s ability to concentrate in keratin makes it especially useful for these conditions.
These effects are usually transient and resolve without medical intervention. Patients should protect their skin from direct sun exposure and use sunscreen while on therapy.
Major Interactions
Moderate Interactions
Food and Lifestyle Interactions
If a patient is taking other medications, supplements, or herbal products, they should inform their healthcare provider before starting Grifulvin V.
Special Populations
Administration Tips
Missed Dose
Overdose
Discontinuation
Regular follow-up appointments enable the prescriber to assess treatment response and adjust dosing if needed.
This article provides educational information about Grifulvin V and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
